ABS Distribution Inc.

Warning LetterOpen

Amanpreet S. Kohli CEO ABS Distribution Inc. 13701 Excelsior Drive Santa Fe Springs , CA 90670 United States aman@absdistro.comFEI 3026760385Issued Jul 27, 2023Center for Tobacco Products

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3026760385.

Violations1

Issue DateJul 27, 2023

Product TypeTobacco

StatusOpen

Letter Details

Firm: ABS Distribution Inc.
Location: Amanpreet S. Kohli CEO ABS Distribution Inc. 13701 Excelsior Drive Santa Fe Springs , CA 90670 United States aman@absdistro.com
FEI Number: 3026760385
Country: United States
Issue Date: July 27, 2023
Issuing Office: Center for Tobacco Products
Product Type: Tobacco
Status: Open

Summary

ABS Distribution Inc. was warned for distributing electronic nicotine delivery system (ENDS) products without required premarket authorization as mandated under the Federal Food, Drug, and Cosmetic Act. The FDA determined the company was offering tobacco products for commercial distribution in the United States without compliance with FDA jurisdiction requirements, including the expanded definition of tobacco products that covers nicotine from any source following legislation signed in March 2022. The company failed to obtain premarket authorization orders for "new tobacco products" as required by law before legally marketing such products in the United States.

ABS Distribution Inc. FDA Warning Letter, July 27, 2023